Two epigenetic regulators interfere with healthy aging

- Posted by admin in English

It has long been assumed that lifespan and health are strongly correlated, but although there has been an overall increase in human life expectancy in recent decades, it is too often accompanied by deterioration of health.

A new study published on February 26 in Nature shows the influence of two epigenetic regulators on aging. Scientists led by Jie Yuan from the Chinese Academy of Sciences in Shanghai have studied the BAZ-2 and SET-6 proteins in Caenorhabditis elegans worms, which are orthologs of the human proteins BAZ2B and EHMT1.

Through genome-wide RNA-interference-based screening of genes that regulate behavioral deterioration in aging C. elegans, the researchers identified 59 genes as potential health modulators during aging. Essentially the proteins expressed by these genes, read and write epigenetic signals.

Among these modulators, they found that a neuronal epigenetic reader, BAZ-2, and a neuronal histone SET-6, accelerate the deterioration of the behavior of C. elegans by reducing the mitochondrial function, and repressing the expression of the encoded mitochondrial proteins. in the cell nucleus.

The researchers found that the levels of the two proteins increase with age in C. elegans and mice, which in turn attenuates the expression of genes involved in mitochondrial function.

BAZ-2 and SET-6 are complementary epigenetic mechanisms. SET-6 is an "epigenetic writer" and BAZ-2 is an "epigenetic reader" which recognizes modified histones and recruits transcriptional regulators.

Histones are proteins located in the nucleus of eukaryotic cells. They are the main protein components of chromosomes. They are closely associated with DNA and allow their compaction, but they also modify the expression of proteins by various epigenetic mechanisms known as the "histone code".

enter image description here Source Wikipedia.

How do BAZ-2 and SET-6 accelerate aging? The researchers found that the two proteins bind together to the promoter regions of more than 2,000 genes, and decrease their expression via methylation of histones. Among these target genes are many mitochondrial genes encoded nuclear. By suppressing the expression of these genes, BAZ-2 and SET-6 reduce oxygen consumption and ATP production, and decrease the critical stress responses that maintain mitochondrial proteostasis. The resulting metabolic slowdown discourages the worms from assimilating their food and they mate less.

This mechanism is conserved in the neurons of cultured mice and human cells. What about the orthologs of these epigenetic proteins in humans? A review of the databases shows that expression by human orthologs of the two proteins mentioned above, BAZ2B and EHMT1, increases with age and is positively correlated with the progression of Alzheimer's disease. Researchers have verified that ablation of BAZ-2 mouse ortholog Baz2b attenuates age-dependent body weight gain and prevents cognitive decline in aging mice.

enter image description here While wild-type mice grew fat with age, animals lacking both copies of the epigenetic reader Baz2b stayed trim, indicating improved mitochondrial function. [Yuan et al., Nature, 2020.]

However, it must be asked whether BAZ-2 and SET-6 would rather mediate age-related physiological adaptation, rather than the agents of aging itself. Indeed their action could reflect a mechanism of adaptation to a progressively more hostile biological environment.

The authors' findings suggest that NHE7 plays a crucial role in delaying cellular senescence and advancing EC progression through the cAMP pathway, uncovering critical mechanistic drivers of EC pathogenesis and highlighting actionable therapeutic targets.

Read the original article on Pubmed

The authors' prior work with human-induced pluripotent stem cell-derived midbrain neurons generated from patients with Parkinson disease identified neuritic deficits, accompanied by decreased levels of cytoskeletal element -tubulin-III. To explore mechanisms underlying these effects in neurons, the authors used CRISPR-Cas9 to generate isogenic control hiPSCs. Isogenic correction of dosage restored -induced neurite defects and bTubIII levels. Multi-omics analyses revealed -induced alterations in neuronal differentiation, with a notable down-regulation of PAX6. Moreover, induced an up-regulation of vimentin. Further characterization revealed heightened vimentin truncation associated with altered distribution and organization. Similar changes in vimentin levels and truncation were observed in postmortem putamen tissue from patients with sporadic Parkinson disease.

Read the original article on Pubmed

This complex case involved a patient with lip hypermobility and a "gummy smile" who was self-conscious of her aging ceramic restorations. She also lacked a comfortable bite position and desired a restful position for her jaw. The patient was opposed to surgical correction of her lip and temporary botulism toxin injections to decrease the mobility. A treatment plan was produced utilizing a systematic treatment approach that accommodated the patient's treatment preferences and successfully reduced her gingival display, created a comfortable bite, and enhanced her smile, thus achieving all of the patient's goals.

Read the original article on Pubmed

The scientists here aimed to explore the feasibility and safety of nabiximols as a potential treatment for agitation in ad.

Read the original article on Pubmed

The Ageing Surgeon: Unmasking Impairment.

- Posted by system in English

Australian age-related anti-discrimination laws prevent discrimination in the workplace on grounds of age alone. In 2023 8.4% of Australian surgeons and 8.8% of general practitioners were aged 70 years or older. On 7 August 2024, the Medical Board of Australia released a consultation paper seeking comment from the medical profession and the wider community on health checks for late career doctors to consider whether additional safeguards are needed. The MBA's preferred option is to introduce general health checks by a general practitioner for doctors aged 70 and older, to support early detection of concerns with the opportunity for management before the public is at risk. The proposal would require doctors from the age of 70 years to undergo general health checks with their general practitioner or another doctor every three years, and yearly from 80 years of age. Other options are to compel extensive and detailed "fitness to practise" assessment for all doctors aged 70 and older, to be conducted by specialist occupational physicians, or to maintain the status quo, which is essentially a self-reporting requirement.

Read the original article on Pubmed


Please, help us continue to provide valuable information: